BridgeBio to Present Primary Results from the Phase 3 CALIBRATE Trial at 2026 ECE

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. META
4. SPY
5. IBM
6. MU
7. FDX
8. BLZE
9. NKE
10. PRIM

Go back to BridgeBio to Present Primary Results from the Phase 3 CALIBRATE Trial at 2026 ECE
(NASDAQ: BBIO) Delayed: 68.63 -0.29 (0.42%)
Previous Close $68.92    52 Week High $ 
Open $68.57    52 Week Low $ 
Day High $69.90    P/E N/A 
Day Low $68.03    EPS $ 
Volume 2,455,145